The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Diabetes and peripheral artery disease: A review
Open accessAbstract
Peripheral arterial disease (PAD) refers to partial or complete occlusion of the peripheral vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in the coronary and cerebral arteries. The prevalence of PAD is expected to continue to increase in the foreseeable future owing to the rise in the occurrence of its major risk factors. Nonhealing ulcers, limb amputation and physical disability are some of its major complications. Diabetes mellitus (DM) remains a major risk for PAD, with DM patients having more than two-fold increased prevalence of PAD compared with the general population. The clinical presentation in people with DM also differs slightly from that in the general population. In addition, PAD in DM may lead to diabetic foot ulcers (DFUs), which precipitate hyperglycaemic emergencies and result in increased hospital admissions, reduced quality of life, and mortality. Despite the epidemiological and clinical importance of PAD, it remains largely under diagnosed and hence undertreated, possibly because it is largely asymptomatic. Emphasis has been placed on neuropathy as a cause of DFUs, however PAD is equally important. This review examines the epidemiology, pathophysiology and diagnosis of lower limb PAD in people with diabetes and relates these to the general population. It also highlights recent innovations in the management of PAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Fowkes, F. G. R., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J. O., McDermott, M. M., Norman, P. E., Sampson, U. K., Williams, L. J., Mensah, G. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61249-0 · Cited by 3,508
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Selvin, E., & Erlinger, T. P. (2004) · Circulation · doi:10.1161/01.cir.0000137913.26087.f0 · Cited by 1,885
Song, P., Rudan, D., Zhu, Y., Fowkes, F. J. I., Rahimi, K., Fowkes, F. G. R., & Rudan, I. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30255-4 · Cited by 1,317
FOWKES, F. G. R., HOUSLEY, E., CAWOOD, E. H. H., MACINTYRE, C. C. A., RUCKLEY, C. V., & PRESCOTT, R. J. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.2.384 · Cited by 1,181
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000470 · Cited by 1,055
Peripheral arterial disease in people with diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3333 · Cited by 953
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Exercise for intermittent claudication
Lane, R., Harwood, A., Watson, L., & Leng, G. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000990.pub4 · Cited by 822
Peripheral Arterial Disease in the Elderly: The Rotterdam Study
Meijer, W. T., Hoes, A. W., Rutgers, D., Bots, M. L., Hofman, A., & Grobbee, D. E. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.2.185 · Cited by 770
Intermittent Claudication: A Risk Profile From The Framingham Heart Study
Murabito, J. M., D’Agostino, R. B., Silbershatz, H., & Wilson, P. W. F. (1997) · Circulation · doi:10.1161/01.cir.96.1.44 · Cited by 696
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
Hayward, R. A., Reaven, P. D., Wiitala, W. L., Bahn, G. D., Reda, D. J., Ge, L., McCarren, M., Duckworth, W. C., & Emanuele, N. V. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414266 · Cited by 668
Anderson, J. L., Halperin, J. L., Albert, N., Bozkurt, B., Brindis, R. G., Curtis, L. H., DeMets, D., Guyton, R. A., Hochman, J. S., Kovacs, R. J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.004 · Cited by 664
Peripheral Arterial Disease in People With Diabetes
Hoyt, R. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2095 · Cited by 649
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
Hiatt, W. R., Fowkes, F. G. R., Heizer, G., Berger, J. S., Baumgartner, I., Held, P., Katona, B. G., Mahaffey, K. W., Norgren, L., Jones, W. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611688 · Cited by 636
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407963 · Cited by 626
Gregg, E. W., Sorlie, P., Paulose-Ram, R., Gu, Q., Eberhardt, M. S., Wolz, M., Burt, V., Curtin, L., Engelgau, M., & Geiss, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1591 · Cited by 585
Peripheral Arterial Disease in Patients With Diabetes
Marso, S. P., & Hiatt, W. R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.065 · Cited by 575
Global Disability Burdens of Diabetes-Related Lower-Extremity Complications in 1990 and 2016
Zhang, Y., Lazzarini, P. A., McPhail, S. M., van Netten, J. J., Armstrong, D. G., & Pacella, R. E. (2020) · Diabetes Care · doi:10.2337/dc19-1614 · Cited by 560
Hiatt, W. R., Hoag, S., & Hamman, R. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1472 · Cited by 551
Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119503 · Cited by 536
Contributions of polyol pathway to oxidative stress in diabetic cataract
LEE, A. Y. W., & CHUNG, S. S. M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.23 · Cited by 533
Ten Commandments of the 2018 ESC/ESH HTN Guidelines on Hypertension in Adults
Williams, B., & Mancia, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy439 · Cited by 494
Standards of Medical Care in Diabetes—2016: Summary of Revisions
(2016) · Diabetes Care · doi:10.2337/dc16-s003 · Cited by 448
Established Risk Factors and Coronary Artery Disease: The Framingham Study
Wilson, P. W. F. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.7.7s · Cited by 438
Adler, A. I., Stevens, R. J., Neil, A., Stratton, I. M., Boulton, A. J. M., Holman, R. R., & for the U.K. Prospective Diabetes Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.5.894 · Cited by 429
Berger, J. S., Krantz, M. J., Kittelson, J. M., & Hiatt, W. R. (2009) · JAMA · doi:10.1001/jama.2009.623 · Cited by 360
Doobay, A. V., & Anand, S. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168911.78624.b7 · Cited by 341
Kullo, I. J., & Rooke, T. W. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1507631 · Cited by 333
Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Aboyans, V., Criqui, M. H., Denenberg, J. O., Knoke, J. D., Ridker, P. M., & Fronek, A. (2006) · Circulation · doi:10.1161/circulationaha.105.608679 · Cited by 290
Progression of Atheroma: A Struggle Between Death and Procreation
Geng, Y.-J., & Libby, P. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000031341.84618.a4 · Cited by 288
Margolis, K. L., O’Connor, P. J., Morgan, T. M., Buse, J. B., Cohen, R. M., Cushman, W. C., Cutler, J. A., Evans, G. W., Gerstein, H. C., Grimm, R. H., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2334 · Cited by 259
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
Murphy, S. A., Cannon, C. P., Blazing, M. A., Giugliano, R. P., White, J. A., Lokhnygina, Y., Reist, C., Im, K., Bohula, E. A., Isaza, D., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.077 · Cited by 205
Ramos, R., Quesada, M., Solanas, P., Subirana, I., Sala, J., Vila, J., Masiá, R., Cerezo, C., Elosua, R., Grau, M., et al. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.04.013 · Cited by 170
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Fonseca, V., Desouza, C., Asnani, S., & Jialal, I. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0034 · Cited by 168
Drexel, H., Aczel, S., Marte, T., Benzer, W., Langer, P., Moll, W., & Saely, C. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.101 · Cited by 162
Forrest, K. Y. Z., BECKER, D. J., Kuller, L. H., Wolfson, S. K., & Orchard, T. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00217-8 · Cited by 159
Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl441 · Cited by 159
Cilostazol for peripheral arterial disease
Robless, P. A., Mikhailidis, D. P., & Stansby, G. P. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003748.pub3 · Cited by 153
Costa, R. H. R., Cardoso, N. A., Procópio, R. J., Navarro, T. P., Dardik, A., & Cisneros, L. D. L. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.04.008 · Cited by 150
Risk Factors for Recurrent Diabetic Foot Ulcers
Peters, E. J. G., Armstrong, D. G., & Lavery, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0445 · Cited by 123
ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
Reiter–Brennan, C., Osei, A. D., Uddin, S. M. I., Orimoloye, O. A., Obisesan, O. H., Mirbolouk, M., Blaha, M. J., & Dzaye, O. D. A. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.19078 · Cited by 114
The interrelationship between diabetes mellitus and peripheral arterial disease: A systematic review
Stoberock, K., Kaschwich, M., Nicolay, S. S., Mahmoud, N., Heidemann, F., Rieß, H. C., Debus, E. S., & Behrendt, C. (2020) · VASA · doi:10.1024/0301-1526/a000925 · Cited by 101
Exercise Rehabilitation for Peripheral Artery Disease: A REVIEW
McDermott, M. M. (2018) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000343 · Cited by 91
Akalu, Y., & Birhan, A. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9419413 · Cited by 68
Diagnosis and treatment of peripheral arterial disease.
Hennion, D. R., & Siano, K. A. (2013) · PubMed · Cited by 66
An assessment of peripheral vascular disease in patients with diabetic foot ulcer
Ikem, R. T., Ikem, I. C., Adebayo, O., & Soyoye, D. O. (2010) · The Foot · doi:10.1016/j.foot.2010.09.002 · Cited by 65
Self-citationAssociation between plasma homocysteine and peripheral arterial disease in older persons
Aronow, W. S., & Ahn, C. W. (1998) · Coronary Artery Disease · doi:10.1097/00019501-199809010-00008 · Cited by 54
The pattern of presentation of foot lesions in Nigerian diabetic patients.
Akanji, A. O., & Adetuyidi, A. (1991) · PubMed · Cited by 52
Prevalence and Correlates of Peripheral Arterial Disease in Nigerians with Type 2 Diabetes
Soyoye, D. O., Ikem, R. T., Kolawole, B. A., Oluwadiya, K. S., Bolarinwa, R. A., & Adebayo, O. (2016) · Advances in Medicine · doi:10.1155/2016/3529419 · Cited by 46
Self-citationA study of prognostic factors in Chinese patients with diabetic foot ulcers
Wang, A., Sun, X., Wang, W., & Jiang, K.-C. (2014) · Diabetic Foot & Ankle · doi:10.3402/dfa.v5.22936 · Cited by 35
Risk factors of peripheral arterial disease: a case control study in Sri Lanka
Weragoda, J., Seneviratne, R. D. A., Weerasinghe, M. C., & Wijeyaratne, S. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2314-x · Cited by 33
Wang, N., Yang, B., Wang, G., Gao, Y., Cao, X., Zhang, X., Yan, C., Lian, X., Liu, B., & Ju, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28183 · Cited by 33
Bennett, P. C., Lip, G. Y. H., Silverman, S., Blann, A. D., & Gill, P. S. (2010) · QJM · doi:10.1093/qjmed/hcq102 · Cited by 21
Recent advances in endovascular treatment of peripheral arterial disease
Lazar, A. N., & Morrissey, N. J. (2020) · F1000Research · doi:10.12688/f1000research.20398.1 · Cited by 14
Professional Practice Committee: Standards of Medical Care in Diabetes—2020
(2019) · Diabetes Care · doi:10.2337/dc20-sppc · Cited by 12
Treatment Strategies for the Claudicant
Pereira, K. (2018) · Seminars in Interventional Radiology · doi:10.1055/s-0038-1676322 · Cited by 4
Cited by
Diabetic foot ulcers: Classification, risk factors and management
Wang, X., Yuan, C.-X., Xu, B., & Yu, Z. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i12.1049 · Cited by 305
Chen, L., Sun, S., Gao, Y., & Ran, X. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14840 · Cited by 260
Diabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Keller, K., Schmitt, V. H., Vosseler, M., Brochhausen, C., Münzel, T., Hobohm, L., & Espinola-Klein, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215033 · Cited by 31
Metadata
- Authors
- Soyoye, D. O., Abiodun, O. O., Ikem, R. T., Kolawole, B. A., & Akintomide, A. O.
- Venue
- World Journal of Diabetes
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2021-06-15
- Volume
- 12
- Issue
- 6
- Pages
- 827-838
- ISSN
- 1948-9358 (ISSN-L)
- OpenAlex
- W3169874557
- Cited by
- 272
- References
- 71
- FWCI
- 23.73
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.